Kate Burba is an Online Content Editor for Healio, a platform that provides healthcare professionals with up-to-date medical news and information. With a focus on gastroenterology and hepatology, Kate covers a wide range of topics including clinical guidelines, research findings, and advancements in medical care.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kate's coverage predominantly focuses on healthcare and scientific topics, particularly in the field of gastroenterology and hepatology. Her articles frequently cite data, indicating a preference for evidence-based reporting.
Given Kate's focus on specific medical specialties and guidelines, she may be interested in receiving pitches from experts who can provide insights into new research findings or clinical developments within these fields. Additionally, sources with access to relevant data or those involved in the creation of medical guidelines may capture her attention.
As there is no specified geographic focus, pitches should align with global relevance rather than being region-specific.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Heather Biele, Kate Burba
Key takeaways: A speech rate of less than 137 words per minute was tied to higher risk for overt hepatic encephalopathy.
By: Kate Burba, Saqr Alsakarneh, Heather Biele
Primary sclerosing cholangitis is an independent risk factor for colorectal cancer, with an “almost three-times higher” risk among patients without inflammatory bowel disease vs. the general population, a researcher reported.
By: Heather Biele, Kate Burba
Key takeaways: Risks for rebleeding and mortality were similar regardless of vasoconstrictor therapy duration.
By: Kate Burba, Heather Biele
Key takeaways: Fewer patients treated with rifaximin had an overt hepatic encephalopathy episode vs. those treated with lactulose (23.2% vs. 49%).
By: Kate Burba, Heather Biele
pancreatic cancer compared with those on other antidiabetic therapies, regardless of weight, according to data.
By: Kate Burba, Heather Biele
Key takeaways: There were no differences in rates of post-endoscopic retrograde cholangiopancreatography pancreatitis with indomethacin vs. diclofenac.
By: Saqr Alsakarneh, Heather Biele, Kate Burba
Janus kinase inhibitors did not increase the risk for major cardiovascular or thromboembolic events among patients with inflammatory bowel disease compared with anti-tumor necrosis factor therapy, data showed.
By: Kate Burba, Heather Biele
Key takeaways: Patients with cirrhosis had a higher risk for post-EMR bleeding compared with controls.
By: Heather Biele, Kate Burba
Shield test result did not appear to be at increased risk for non-colorectal cancer malignancies at 1 year compared with those with a true-negative result, according to a presenter here.
By: Heather Biele, Kate Burba
Glucagon-like peptide-1 receptor agonist use was associated with prolonged gastric transit time and incomplete small bowel evaluation among patients with diabetes undergoing video capsule endoscopy, according to research.
(833) 317-6278 
